BioSpace News Archive

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced that the Company expects to receive a nine month extension on DEXYCU®’s pass-through payment status, which otherwise would expire on March 31, 2022.

Pacific Biosciences of California, Inc., a leading provider of high-quality, long-read sequencing platforms, announced that it has signed a definitive merger agreement under which it will acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy.

Ortho Regenerative today announced that it has provided and filed all requested CMC-related data and characterization information in a formal response to the U.S. Food and Drug Administration.

Rivus Pharmaceuticals, Inc. today announced the completion of a $35 million Series A financing

Collaboration to leverage IONTAS proprietary mammalian display technology and other world-class discovery technologies

Mevion Medical Systems announced today that it has delivered the 15-ton compact accelerator to Mercy Hospital St. Louis in Missouri.

EQRx today announced the formation of its mission advisory board.

Mindset Pharma Inc. today announced the appointment of Dr. Ishrat Husain to its Scientific Advisory Board.

TRACON Pharmaceuticals announced today the appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and the granting of an inducement equity award to Dr. Marczi.

MiMedx Group, Inc., an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, announced that it will report operating and financial results for the second quarter ended June 30, 2021 after the market close on Tuesday, August 3, 2021.